Literature DB >> 6233198

The influence of genetic background on the susceptibility of inbred mice to streptozotocin-induced diabetes.

J Wolf, F Lilly, S I Shin.   

Abstract

Multiple low-dose injections of streptozotocin (STZ) induce a delayed but progressively increasing state of hyperglycemia in mice. Different inbred strains of mice show different susceptibility to this treatment. We examined whether genetic factors associated with the H-2 complex influence the susceptibility or resistance, using a selected group of 12 inbred and 5 congenic resistant strains of mice. We found that different congenic strains differed significantly in their susceptibility to STZ-induced diabetes, suggesting that H-2-associated genes do influence the susceptibility. However, at least some inbred strains sharing the same H-2 haplotype also differed in their susceptibility, indicating that genes outside the H-2 complex may also affect the susceptibility. Therefore, there appear to be at least two genes, one within and one or more outside the H-2 complex, that determine the susceptibility to multiple low doses of STZ.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6233198     DOI: 10.2337/diab.33.6.567

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  A single major gene controls most of the difference in susceptibility to streptozotocin-induced diabetes between C57BL/6J and C3H/HeJ mice.

Authors:  K Kaku; J McGill; M Province; M A Permutt
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

2.  Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in CD-1 mice.

Authors:  J R Wright; J B Lefkowith; G Schreiner; P E Lacy
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

3.  Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice.

Authors:  L Wen; F S Wong; L Burkly; M Altieri; C Mamalaki; D Kioussis; R A Flavell; R S Sherwin
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

4.  Susceptibility to db gene and streptozotocin-induced diabetes in C57BL mice: control by gender-associated, MHC-unlinked traits.

Authors:  E H Leiter; P H Le; D L Coleman
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

5.  Multiple low-dose streptozotocin-induced diabetes in the mouse: further evidence for involvement of an anti-B cell cytotoxic cellular auto-immune response.

Authors:  R C McEvoy; N M Thomas; C Hellerström; F Ginsberg-Fellner; T M Moran
Journal:  Diabetologia       Date:  1987-04       Impact factor: 10.122

6.  The anti-diabetogenic effect of essential fatty acid deficiency in multiple low-dose streptozotocin-treated mice persists if essential fatty acid repletion occurs outside of a brief window of susceptibility.

Authors:  J R Wright; B Haliburton; H Russell; M Henry; R Fraser; H W Cook
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

Review 7.  Maternal hyperglycemia and fetal cardiac development: Clinical impact and underlying mechanisms.

Authors:  Madhumita Basu; Vidu Garg
Journal:  Birth Defects Res       Date:  2018-12-01       Impact factor: 2.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.